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ABSTRACT 
 
SHAPE Analysis of 5’ Untranslated Region of Mouse Hepatitis Virus.  
(April 2011) 
 
Faryal Masud 
Department of Biochemistry and Biophysics  
Texas A&M University 
 
Research Advisors:  Dr. Julian Leibowitz and Dr. Dong Yang 
Department of Microbial and Molecular Pathogenesis 
 
 
 
Software called SHAPE finder was used to analyze the secondary structure 5’ 
UTR of MHV. This study was the first time this software has been used for MHV, 
and if the previous procedures are followed, we will have high resolution results 
of the RNA secondary structures. Currently, the replication and pathogenesis of 
MHV is incompletely understood in part because of a lack of an accurate 
determination of its RNA secondary structure. This will help us better understand 
its course of proliferation. Since MHV is a good model for other coronaviruses 
and structures important for replication are most often conserved amongst closely 
related viruses, this information may provide a better understanding of the 
replication of related coronaviruses such as SARS-coronavirus. 
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CHAPTER I 
INTRODUCTION
1
 
 
Mouse Hepatitis Virus (MHV) is a group two coronavirus of the Coronaviradae 
family in the order Nidovirales (6). It is a positive sense, single-stranded RNA 
virus that is 32 kb long. MHV provides a good animal model virus for a plethora 
of human diseases. The most recognized is Severe Acute Respiratory Syndrome 
(SARS) which is also caused by a coronavirus (18). A prerequisite for gaining an 
understanding of MHV pathogenesis is to study its means of replication. From 
previous studies, it is well known that the 5’ untranslated region (UTR) of MHV 
contains cis-acting elements that are essential for viral replication (12, 14). The 
question that now arises is how this 5’ UTR is involved in RNA-RNA 
interactions, RNA-protein interactions and other such important interactions that 
play a part in the replication and infection by the virus. In order to answer this 
question, a detailed understanding of the RNA secondary structures in this region 
of the virus must be identified.  
 
Thus far, a proposed model for the first 140 nucleotides of the 5’ UTR has been 
identified using phylogenetic evidence from nine other coronaviruses and other 
                                                 
This thesis follows the style of Journal of Virology 
2 
 
software such as Vienna RNA, Mfold and PKNOTS (10, 12, 20). These programs 
use tools such as free energy minimization for a given sequence, folding kinetics, 
and phylogenic evidence from RNA structures of related sequence families (2, 15-
16). Vienna RNA in particular was utilized by Liu, et.al 2007 to examine the 5’ 
UTR secondary structures of five group two coronaviruses, BCoV, human 
coronavirus HCoV-OC43, MHV-A59, HKU1, and SARS-CoV; three group one 
coronaviruses, HCoV-NL63, HCoV-229E, and TGEV and one group three 
coronavirus avian CoV IBV.  Free energy minimization folding showed similar 
structures in the first 150 nt of the 5’ UTR of three helical stems designated SL1, 
SL2, and SL4 (12). Of the group two viruses, two, HCoV-0C43 and SARS-CoV, 
were predicted to contain a fourth stem loop SL3. Figure 1 illustrates these 
structures. Although these are useful tools for identifying putative secondary 
structures, they are only 40-70% accurate (3). Most biochemical methods of 
determining RNA secondary structure can only be applied to short fragments of 
RNA. SHAPE, selective 2’-hydroxyl acylation analyzed by primer extension, is a 
new RNA analysis technique that can give the overall secondary structure at 
single nucleotide resolution for the entire genome (22). I will compare the 
secondary structure of the 5’ UTR 140 nucleotide region, as determined by 
SHAPE, to that of the proposed model generated from phylogenetic evidence 
given by that of nine coronaviruses (12). As mentioned, all nine of the 
coronaviruses contain three stem loop secondary structures in their 5’ UTR 
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despite having significant sequence differences and because of this, my 
hypothesis is that the 5’ UTR 140 nucleotide region will contain these three stem 
loop structures as well. 
 
FIG 1. Models of 5’ UTR of nine coronaviruses. From Liu, et al. 2007, 
this figure is a good illustration of the predicted models of the 5’ UTR of 
the nine coronaviruses discussed. 
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The mechanism by which SHAPE works involves a chemical reaction between an 
electrophile, in this case 1-methyl-7-nitroisatoic anhydride (1M7), and flexible 
RNA nucleotides containing the ribose 2’ hydroxyl group that all RNAs have (17, 
23). These flexible RNA nucleotides must be exposed to sufficient concentrations 
of 1M7 to yield at least one 2’- O adduct per 300 nucleotides (23). After 
formation of these adducts, primers are annealed to the template to generate 
cDNA using reverse transcription. The adducts are detected by their ability to 
block the reverse transcription process (23). The control in this experiment is a 
separate RNA that is run without the use of 1M7 to subtract background (23). The 
cDNAs are finally resolved by electrophoresis, typically on a sequencing/genetic 
analyzer, and quantified nucleotide by nucleotide eliminating background. Higher 
band intensity is correlated with high reactivity. High reactivity indicates a region 
of unpaired nucleotides whereas a region of low intensity indicates the presence 
of secondary structures. SHAPE has thus far not been applied to MHV. Before 
getting to this thorough analysis of the virus, a standard must be used to test the 
primer extension and SHAPE software. We will be using pUC-18 cDNA standard 
and four primers each with a different fluorescence label to test the reaction. 
 
SHAPE has been applied to determine the RNA secondary structures of other 
viruses such as HIV-1 (23). They used a method applying SHAPE to four 
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different states of the virus including the in virio state meaning recovering virus 
genome from inside the native HIV virus, the ex virio state meaning the HIV 
genome deproteinized and extracted from the virus capsid, an in vitro transcript of 
HIV, and a slightly modified in viro virus with disrupted interactions between the 
capsid and RNA.  For our study with MHV, we will be focusing on two of these 
relevant states, the in virio and ex virio states for the 5’ 950 nt of the 5’ UTR and 
part of the coding region, nsp1. The first 474 nts of this region contains cis-acting 
sequences required for replication. Nsp1 is a 28 kilodalton gene that generates one 
of the first processed proteins of the virus and is believed to have a crucial role in 
the early life cycle MHV (1, 4). In another study, SHAPE was used to identify the 
secondary structures in the entire HIV-1 genome (22). They discovered that 
noncoding regions, such at the UTR in MHV, have many more secondary 
structures than the coding regions of the virus. My hypothesis for this 950 nt 
region is that those sequences in the 5’ UTR will be more highly structured than 
that of the coding nsp1 region based on this study by Watts et. al 2009. 
 
The electropherograms generated from SHAPE experiments provide much 
structural information that must then be analyzed with significantly complex 
algorithmic steps to generate quantitative data. Vasa, et al. 2008 developed a set 
of tools called ShapeFinder to more quickly analyze the raw electropherograms 
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without complex steps. These simplifications using this software tool include 
converting fluorescence intensity to quantitative cDNA concentrations, correcting 
for signal decay, and aligning reactivity data to the known RNA sequence (21). 
Therefore, we will be using Shapefinder to analyze our data generated by SHAPE 
reactions. 
 
If all of this holds true, the next part of the experiment would be to determine the 
presence of secondary structures determined by SHAPE using the reverse genetic 
approach. In previous experiments, both biochemical and reverse genetic 
approaches have been used to determine structure of the 3’ UTR of MHV and test 
proposed models. The biochemical approach is prevalent in earlier works of the 3’ 
UTR. The Masters lab in 2000 added to a proposed structure of the 3’ UTR by 
showing that a previously identified bulged stem loop consisting of five bulges 
actually had larger terminal and internal loops than previously thought (7-8). In 
2001, the Leibowitz lab illustrated by disrupting base pairing that several essential 
stem loops that make up two host protein binding elements exist in the last 166 nt 
of the 3’ UTR using DI RNA replication (13). The reverse genetic approach was 
then utilized by Goebel, et al. in 2004. This involves making point mutations in 
the viral sequence to test the viability of the virus which is then measured by viral 
ability to infect cells (5). This approach is known to be successful and has been 
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applied to a model of the 3’ UTR and tested by Johnson, et al. in 2005 (9).  These 
same tests can be applied to the 5’ UTR. It is clear that knowledge of the 5’ UTR 
secondary structure of MHV and its interactions with other proteins and RNAs is 
vital to understanding its means of proliferation and has applications in 
developing treatments.  
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CHAPTER II  
METHODS 
 
Virus production 
Virus and cell media 
 17CL-1 cells were grown with Dulbecco’s modified Eagle medium (Life 
Technologies) supplemented with 10% fetal bovine serum, 4 mM glutamine and 
penicillin/streptomycin. Trypsin was used to passage cells. MHV-A59 was 
propagated in 17CL-1 cells as previously described (11).  The virus was clarified 
of cellular debris with centrifugation following a previous, successful protocol 
(11). 
 
Molecular cloning of A fragment of MHV 
Bacterial media 
 LB broth and 100 µg/mL ampicillin was used to grow E. coli containing the 
plasmids. pLitmus 38 and the A plasmid from the MHV reverse genetic system 
(24-25). 
Minipreps 
 The Qiagen miniprep kit and protocol were used. Cells were centrifuged at 5000 
rpm for 2 minutes in microcentrifuge tubes, the  supernatant decanted leaving the 
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cell pellet. The pellet was dissolved in buffer P1 + RNase A by vortexing. Cells 
were lysed by the addition of buffer P2 lysis solution with gentle mixing. 
Neutralization buffer N3 was added and mixed gently and the lysed bacteria 
centrifuged at 12,000 rpm for 10 minutes. Supernatant was added to a QIAprep 
column in a 2 mL collection tube, centrifuged for 30 seconds and additional 
supernatant was added to the column and centrifuged a second time.  Columns 
were washed with buffer PE and dried by centrifugation. QIAprep columns were 
placed in new collection tubes and eluted DNA with buffer EB (10 mM Tris-HCl, 
pH 8.5). We stored samples at -20° C.  
Agarose gel electrophoresis 
 Agarose gels (0.8%) buffered with 1X TAE and contained ethidium bromide as 
the DNA staining agent. Samples contained 6X DNA dye and a 1kb DNA ladder 
was used as marker.  Electrophoresis was for 45 min at 120V. Gels were 
photographed under UV light. 
PCR 
 PCR reactions were assembled using 5 PRIME Master Mix, forward and reverse 
primers, and plasmid samples. (See Table 1 for PCR primer sequences). PCR was 
carried out as follows: 1 cycle 96°
 
 C 1 min, 30 cycles of 96°
 
C 30 sec, 60°
 
 C 30 
sec, 72° C 2 min, 1 cycle 72° C 15 min, hold at 4° C. 
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Gel purification 
 After agarose gel electrophoresis, the desired fragment was excised with a scalpel 
and the DNA extracted from the gel and purified using the Qiagen gel purification 
kit according to the Vendors instructions.  Briefly, gel slices were weighed and 
added appropriate volumes of buffer to solubilize the gel. Incubated at 50° C for 
10 min. Isopropanol was added to the sample and bound to the DNA binding 
column. Washed with buffer PE, and eluted with water. 
Quantification 
 DNA was quantified by UV spectrophotometry using a Nanodrop 
Spectrophotometer. 
Restriction Digest 
 Spe I and Mlu I was utilized from NEB along with appropriate buffers for 
digestion of A fragment and. pLitmus 38. 
Ligation 
 Purified pLitmus 38 and A fragments were taken to create a ligation reaction 
using T4 DNA ligase and buffer. 
Transformation 
 Top 10 electrocompetent cells were used in electroporation. With ligation 
product and cells, electroporated 1 time at 2.5 kV with a time constant of 4.64. To 
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the mixture SOC media was added and put in shaker at 37° C for 1 hour. Spread 
onto LB amp plates. 
Plate counting 
 Picked eight colonies and put into LB amp media and shook over night at 37° C. 
Sequencing reaction 
 Big-Dye mix, miniprep template, water, forward primer in one, reverse primer in 
the other was added to PCR tubes. (See Table 2 for sequencing primer sequences) 
Sequencing program: 1 cycle 96°
 
C 2 min, 35 cycles of 96°
 
C 20 sec, 50°
 
C 10 
sec, 60° C 4 min, hold at 4° C. 
 
Labeling and modification 
Synthesis of 1M7 
 The detailed procedure for the synthesis of 1M7 was generously given to us by 
the Kevin Weeks laboratory. 4NIA was dissolved in 60mL of DMF and added to 
NaH in 15mL DMF, stirring in a flame dried round bottom flask under N2 gas. A 
bright cloudy orange solution resulted at first which turns clear orange after a few 
minutes. 1.5 g of dissolved MeI was added dropwise and stirred at room 
temperature for four hours. The reaction was poured into 100 mL cold 1M HCl 
and the resulting orange precipitate collected by vacuum filtration, washed with 
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ice cold water and then with ether. The 1M7 was dried overnight in a vaccum 
oven in a watch glass. The final product yield should be around 79% and is a 
bright orange powdery solid. NMR was completed with the following specs: 1H 
NMR (CO(CD3)2, 400 MHz) 3.69 (s, 3H, -NCH3-), 8.12 (dd, J=8.8 Hz, 2 Hz, 1 
H, ArH), 8.2 (d, J=2hz, 1h, ArH), 8.34 (d, J=8.4 Hz, 1 H, ArH).  
Creating primers 
 Four good primers were selected in terms of GC content, minimal ability to form 
dimers or hairpins, and melting temperature sites closest to the 5’ end of the pUC-
18 standard and ordered from Eurofins. One good priming site for MHV-A59 was 
also selected. The results were four primers of that would yield products of size 
186, 219, 237, and 273. The MHV primer is in positions 261-282. (See Table 2 
for primer sequences.) 
Labeling primers 
 We purchased the fluorescence dyes JOE, TAMARA, FAM and ROX through 
ANASPECT and used the Invitrogen labeling protocol (19). The oligonucleotide 
was dissolved in deionized water, extracted three times with chloroform and then 
precipitated with 3 M NaCl and ethanol. After mixing well and incubating at –80° 
C for 30 minutes the solution was centrifuged at ~12,000 × g for 30 minutes. The 
supernatant was removed; the pellet was rinsed twice with cold 70% ethanol and 
dried under vacuum. The dry pellet is dissolved in deionized water to achieve a 
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final concentration of 25 μg/μL and stored at –20° C.  A 0.1 M sodium tetraborate 
buffer was prepared by dissolving 0.038 g of sodium tetraborate decahydrate per 
mL of waterand the pH adjusted with HCl to 8.5. This tetraborate labeling buffer 
was prepared as close as possible to the time of labeling. We dissolved 250 μg of 
the amine-reactive compound in 14 μL DMSO. For FAM and TAMRA 
succinimidyl ester, we used 200 μg for100 μg of oligonucleotide and allowed the 
compound to equilibrate to room temperature before opening. The material was 
dissolved by pipetting and washing the sides of the vial. To the vial containing the 
reactive label in DMSO, we added:  deionized water, labeling buffer, 
oligonucleotide stock solution. The reaction was incubated for at least six hours or 
overnight at room temperature placing the vial on a shaker oscillating at low 
speed, gently vortexing to mix the vial every half hour for the first two hours to 
ensure that the reaction remained well mixed. After six hours, 50–90% of the 
amine-modified oligonucleotide molecules are labeled. The labeled 
oligonucleotide was precipitated by adding3 M NaCl and cold 100% ethanol to 
the vial, mixing well and incubating at –20° C for 30 minutes.  The precipitated 
labeled oligonucleotide was recovered by centrifugation at ~12,000 × g for 30 
minutes. We removed the supernatant, rinsed the pellet once or twice with cold 
70% ethanol, and dried briefly. 
Purifying the Labeled Oligonucleotide by Gel Electrophoresis (19) 
 To purify the labeled oligonucleotide by gel electrophoresis, we poured a 20% 
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polyacrylamide gel, resuspended the pellet from ethanol precipitation in 50% 
formamide, and incubated at 55° C for 5 minutes. The oligonucleotide was loaded 
onto the gel and also loaded an adjacent well with 50% formamide plus 0.05% 
bromophenol blue. Electrophoresis was performed until the bromophenol blue 
indicator dye was two-thirds of the way down the gel.  We removed the gel from 
the glass plates, placed it on Saran Wrap, and laid it on a fluorescent TLC plate. 
The labeled and unlabeled oligonucleotides were located by illuminating with a 
UV source. The band containing the labeled oligonucleotide was cut out with a 
scalpel and the oligonucleotide eluted by the chopping it into pieces and 
incubating overnight on a rotator in 4° C.  
Creating standard 
 A culture of E. coli containing pUC-18 was grown overnight in LB containing 
ampicillin at 37° C. The culture was inoculated into a larger flask of LB amp and 
grown at 37°C over night. Plasmid DNA was extracted using the Omega Plasmid 
MidiKit.  Plasmid was quantified with a Nanodrop spectrophotometer to 
determine how much enzyme to digest it with. Restriction digests with BamHI or 
PstI were performed in the appropriate NEB buffer at 37° C over night. 
Restriction digestion was monitored by agarose gel. When the digestion was 
complete, we proceeded to add chloroform and NaOAc, followed by 
centrifugation for two minutes and transfer of the top layer into a new 1.5 mL 
tube and precipitating the digested DNA by the addition of 100% ethanol. After 
15 
 
incubating at -80° C for 1-4 hours the DNA was pelleted by  centrifugation for 10 
minutes. The supernatant was discarded and pellets washed in 100% ethanol and 
recovered by centrifugation for 5 minutes. Alcohol was poured off and the pellet 
dried for 20 minutes and dissolved in water. We next digested the samples with 
AatII in NEB buffer 3 and an appropriate volume of water over night at 37° C. 
The sample was electrophoresed in an agarose gel with the entire sample and 
performed a gel extraction with Qiagen kit to retrieve the smaller fragment of 
pUC-18 that we needed for testing our primers in a SHAPE reaction. 
The following is a summary of the proposed experiment design for this project 
and follows the procedures done by Watts et. al in 2009 when using SHAPE to 
study the secondary structures in HIV-1: 
 
1. Virus Production: MHV-A59 strain that I will be working will infect 17CL-1 
cells. At 72 hours after the infection, viruses will be purified from culture 
supernatants by low speed centrifugation to remove cellular debris followed 
by ultracentrifugation through a sucrose pad and resuspended in MOPS 
buffer, pH 6.6, containing monovalent and divalent ions that are consistent 
with maintaining the RNA secondary structure. RNA will be quantified by 
quantitative reverse-transcription PCR. Half of the sample will be frozen at -
80°C to be used as the in virio state while the remaining aliquot will be used 
as the ex virio state. 
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2. RNA modification: Treat the ex virio aliquot with subtilisin (an agent used to 
remove proteins from the RNA). Subdivide this sample again into that treated 
with 1M7 and that which will remain untreated. The same procedure should 
be mimicked for the frozen in virio sample without subtilisin treatment. This 
RNA should then be purified using a prepared kit. 
3. Primer extension: The necessary primers will be annealed to the template of 
both the modified and the control RNA. This will allow the production of 
cDNA in a reverse transcription reaction. 
4. Capillary electrophoresis and data processing: Instead of running a sequencing 
gel, capillary electrophoresis on an ABI 3130 sequencing instrument can 
resolve the cDNA. Shapefinder software can use the raw electrograms to 
generate data based on fluorescence intensity on a nucleotide by nucleotide 
resolution level. 
5. Reverse genetic approach: If novel unforeseen secondary structures are 
elucidated, then this method will be used to discover the functional role of 
these structures. This involves piecing together an entire cDNA fragment of 
MHV containing the 5’ UTR and creating mutants that have a mutation in the 
novel secondary structure that are predicted to disrupt function if the structure 
is important to function. This should be compared to the wild type MHV. 
From here the viral RNA transcript is electroporated into the desired cell line 
and the cultures are observed microscopically over 3 days to search for 
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evidence of virus replication. A plaque assay is performed after this to 
determine the effectiveness of the virus at replicating. These plaques will 
finally be picked, amplified in cell culture, and reverse transcribed and 
sequenced to see the final sequence of the virus recovered. I have conducted 
previous studies using the reverse genetic approach for the 3’ UTR and 
completed a manuscript for this data that will soon be published. 
 
TABLE 1. Forward and reverse PCR primers 
PCR Primers Sequence 
Forward GCGACTAGTTATAAGAGTGATTGGCGTCCG 
Reverse CGTACGCGTAAAGGGCCTTGGAGGTAGTCACTCTAGTT
GAGGCCTCCACCTTCTGGGGATCCTCATCTAC 
 
TABLE 2. Sequencing primers 
Sequencing Primer  Sequence 
26-47 afrag GTAGTTTAAATCTAATCTAATC 
282-261 afrag GGGTTACCCAACTTCTCCGATG 
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TABLE 3. Single stranded amplification primers 
Primer Sequence 
pUC 18-273 CAGAGCAGATTGTACTGAGAG 
pUC 18-237 GTGAAATACCGCACAGATGC 
pUC 18-219 GCGTAAGGAGAAAATACCGCATC 
pUC 18-186 CGCCATTCAGGCTGCGCAACTG 
A59 (-) -282-261 ATGCGTTCGGAAGCATCCATGG 
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CHAPTER III 
RESULTS 
 
Virus production 
A small scale comparison of virus yield from 17CL1 cells or DBT demonstrated 
that 17CL1 cells produced 2-5 times more virus than DBT cells. Thus far 19 L of 
virus has been produced by infection of 17CL1 cells. This virus has thus been 
clarified of cellular debris and is being stored in the -80°C freezer. 
 
Benchtop SHAPE experiment 
Following the Weeks protocol, an orange-colored powder was created that was to 
be used in our modification reactions. The first time, the powder was determined 
by NMR to only be about 30% of the desired product (1M7). In a second 
synthesis, the powder was determined to be 70% of the desired product. The 
product is stored in a vacuum desiccator over desiccant at room temperature. The 
following is the H-NMR spectrum of the final product. 
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FIG 2. 1H-NMR spectrum of 1M7 product. The sample was solubilized in 
deuterated acetone. There is some residual ether from washing the 
product. The 6 H proton spikes indicate the presence of the desired 
product. 
 
Molecular cloning of A fragment 
Molecular cloning was a success. I created clones of the plasmid containing the A 
fragment in pLitmus 38. Six out of the eight colonies were the correct size of 3.2 
kb (2.7 + 500 bp of vector and A); however only one had the correct sequence 
when confirmed with a sequencing reaction. 
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FIG 3.  pLitmus 38  with A insert. Marked lanes 1, 4-8 appear to have the 
correct insert from the size of the fragment (excluding marker lane). When 
sent for sequencing, only the sample in lane 5 had the desired sequence. 
 
Labeling primers with fluorescent dyes 
Primers from Table 3 were successfully labeled following the protocol using JOE, 
ROX, TAMARA, and FAM nearing 90-100% efficiency. The following is a 
sample calculation of labeling efficiency: 
For JOE, the spectrophotometer gave us an absorbance of 1.137 at 260 nm and 
0.3535 at 520 nanometers. The correction factor given to us by the company for 
JOE was .25. The extinction coefficients at 260 and 520 were 75,000 and 
200,3000 respectively. 
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To test the accuracy of the spectrophotometer, we used the Nanodrop data: 
                                  
     
     
 
     
      
  
       
       
             
The results were similar enough that we could trust either instrument to give us 
the correct labeling efficiency. Table 4 outlines all of the dye efficiencies. 
 
TABLE 4. Efficiency of labeling 
Dye  Efficiency using 
spectrophotometer: 
Efficiency using 
Nanodrop: 
JOE-237 96% 102% 
JOE-viral (282-261) 90% 92% 
TAMARA-219 108% 104% 
TAMARA-viral (282-261) 95% 95% 
ROX-186 106% 107% 
ROX- viral (282-261) 107% 115% 
FAM-273 126% 109% 
FAM- viral (282-261) 102% 100% 
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Single stranded amplification of pUC 18 fragment 
pUC 18 was successfully purified and digested with BamH I; this template 
however, lead to nonspecific priming when single stranded amplification was 
attempted despite several attempts with different PCR conditions as seen in 
Figure 4. 
 
FIG 4. Nonspecific priming in single stranded amplification. Lane 1-
marker. Lane 2-186 fragment shows the correct size fragment without 
nonspecific priming. Lanes 3-4 show multiple bands indicative of 
nonspecific priming. 
 
The template was then digested with Bam H I and and Aat II to create a smaller 
fragment in an attempt to eliminate nonspecific priming. After adjusting 
conditions with gradient PCR, I was able to get the desired fragments as seen in 
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Figure 5. However, when these samples were sent to be run on the 
electropherogram, the results were inconclusive. 
 
FIG 5. Single stranded amplification. Lane 1-marker. Lane 2-186 bp 
fragment. Lane 3-one fragment however the size is incorrect being the size 
of the whole template about 500 bp. Lane 4-237 bp fragment. Lane 5-273 
bp fragment. 
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CHAPTER IV 
DISCUSSION AND CONCLUSIONS 
 
There are several reasons as to why the standards may not have been read by the 
electropherogram to give us our raw standard data. After running a gel 
purification with the entire single stranded amplification product, it is possible 
that much of the product was lost in the purification process as the original bands 
visible on the gel were very faint indication low concentration. In previous runs, 
fragments of that size were known to appear faint because of their small size so 
the experiment was continued in an attempt to get a baseline for our viral 
experiments. In our next approach, I will amplify up to ten reactions instead of 
five and pool the products before purification. As of now, the 237 bp fragment has 
yet to primed and amplified and I have only been able to amplify the entire 
template. I will attempt to get a standard from pLitmus 38 to replace this 
fragment, and label its primer. This primer is sure to generate the desired 
fragment as it has previously been used for sequencing. 
 
The currently ongoing step is labeling the A-59 primer that will be used in primer 
extension to create viral cDNA. After we obtain a standard we will linearize the 
viral DNA with Mlu I, gel purify it and perform in vitro transcription to generate 
RNA. The next step will be to run a PAGE gel in order to get the desired 500 bp 
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segment that we need. We will then purify the RNA purify and set up a reverse 
transcription reaction to generate cDNA. Finally we will sequence with the 
electropherograms. One sample will be modified with 1M7 and the other will not 
be modified as outlined in the methods. These sample data can finally be input 
into ShapeFinder which will automatically subtract the standard and we will be 
able to view the secondary structures in the 5’ UTR. 
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